Skeletal muscle samples were prepared, processed, and analyzed as previously described by Lira
et al. (36 (
link)). The following antibodies and respective dilutions were used for immunoblots: sequestosome 1 (SQSTM1) (p62) (P0067, 1:1000), ULK1 (A7481, 1:1000),
FLAG (F1804, 1:1000) from MilliporeSigma, ULK2 (HPA009027, 1:500) from MilliporeSigma, next to breast cancer type 1 susceptibility protein gene 1 protein (NBR1) (sc-130380, 1:1000) from Santa Cruz Biotechnology (Dallas, TX, USA),
LC3A/B (4108, 1:1000),
ubiquitin (3936, 1:1000), cathepsin B (CTSB) (31718, 1:1000), lysosomal associated membrane protein 1 (
LAMP1) (9091, 1:1000), autophagy related protein (
Atg)13 (13273, 1:1000),
Atg14 (5504, 1:1000), phosphorylated (p-)Atg14 (S29) (13155, 1:1000) from Cell Signaling Technology (Danvers, MA, USA), ULK2 (NBP1-33136, 1:500) from Novus Biologicals, p-p62 (S403) (MABC186-I, 1:1000) from MilliporeSigma,
p-Atg13 (S318) (600-401-C49S, 1:1000) from Rockland (Limerick, PA, USA), and 20S (ab22673, 1:1000) from Abcam (Cambridge, United Kingdom). Results for protein expression were normalized to Ponceau stain.
Fuqua J.D., Mere C.P., Kronemberger A., Blomme J., Bae D., Turner K.D., Harris M.P., Scudese E., Edwards M., Ebert S.M., de Sousa L.G., Bodine S.C., Yang L., Adams C.M, & Lira V.A. (2019). ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle. The FASEB Journal, 33(11), 11735-11745.